| Bacteriophage penetration in vertebrates K Dabrowska, K Switała‐Jelen, A Opolski, B Weber‐Dabrowska, A Gorski Journal of applied microbiology 98 (1), 7-13, 2005 | 336 | 2005 |
| Interactions between bacteriophage, bacteria, and the mammalian immune system JD Van Belleghem, K D±browska, M Vaneechoutte, JJ Barr, PL Bollyky Viruses 11 (1), 10, 2018 | 296 | 2018 |
| Biotechnological applications of bacteriophages: state of the art LK Harada, EC Silva, WF Campos, FS Del Fiol, M Vila, K D±browska, ... Microbiological research 212, 38-58, 2018 | 288 | 2018 |
| Bacteriophage translocation A Górski, E Ważna, BW D±browska, K D±browska, K ¦witała-Jeleń, ... FEMS Immunology & Medical Microbiology 46 (3), 313-319, 2006 | 269 | 2006 |
| Phage as a modulator of immune responses: practical implications for phage therapy A Górski, R Międzybrodzki, J Borysowski, K D±browska, P Wierzbicki, ... Advances in virus research 83, 41-71, 2012 | 262 | 2012 |
| Mammalian Host-Versus-Phage immune response determines phage fate in vivo K Hodyra-Stefaniak, P Miernikiewicz, J Drapała, M Drab, ... Scientific reports 5 (1), 1-13, 2015 | 249 | 2015 |
| Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review K D±browska Medicinal research reviews 39 (5), 2000-2025, 2019 | 228 | 2019 |
| Immunogenicity studies of proteins forming the T4 phage head surface K D±browska, P Miernikiewicz, A Piotrowicz, K Hodyra, B Owczarek, ... Journal of virology 88 (21), 12551-12557, 2014 | 174 | 2014 |
| Phage therapy: combating infections with potential for evolving from merely a treatment for complications to targeting diseases A Górski, R Międzybrodzki, B Weber-D±browska, W Fortuna, S Letkiewicz, ... Frontiers in microbiology 7, 1515, 2016 | 160 | 2016 |
| Oral application of T4 phage induces weak antibody production in the gut and in the blood J Majewska, W Beta, D Lecion, K Hodyra-Stefaniak, A Kłopot, ... Viruses 7 (8), 4783-4799, 2015 | 152 | 2015 |
| Phages and immunomodulation A Górski, K D±browska, R Międzybrodzki, B Weber-D±browska, ... Future microbiology 12 (10), 905-914, 2017 | 149 | 2017 |
| Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies K D±browska, ST Abedon Microbiology and Molecular Biology Reviews 83 (4), e00012-19, 2019 | 143 | 2019 |
| Phage therapy: what have we learned? A Górski, R Międzybrodzki, M Łobocka, A Głowacka-Rutkowska, ... Viruses 10 (6), 288, 2018 | 128 | 2018 |
| Effects of bacteriophages on free radical production and phagocytic functions A Przerwa, M Zimecki, K ¦witała-Jeleń, K D±browska, E Krawczyk, ... Medical microbiology and immunology 195 (3), 143-150, 2006 | 124 | 2006 |
| Phage therapy efficacy: a review of the last 10 years of preclinical studies LDR Melo, H Oliveira, DP Pires, K Dabrowska, J Azeredo Critical reviews in microbiology 46 (1), 78-99, 2020 | 121 | 2020 |
| Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool Z KaĽmierczak, A Górski, K D±browska Viruses 6 (7), 2551-2570, 2014 | 115 | 2014 |
| New insights into the possible role of bacteriophages in host defense and disease A Gorski, K Dabrowska, K Switala-Jeleń, M Nowaczyk, ... Medical Immunology 2 (1), 1-5, 2003 | 115 | 2003 |
| Bacteriophages and transplantation tolerance A Górski, M Kniotek, A Perkowska-Ptasińska, A Mróz, A Przerwa, ... Transplantation proceedings 38 (1), 331-333, 2006 | 108 | 2006 |
| Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes R Miedzybrodzki, K Switala-Jelen, W Fortuna, B Weber-Dabrowska, ... Virus research 131 (2), 233-242, 2008 | 103 | 2008 |
| T4 phage and its head surface proteins do not stimulate inflammatory mediator production P Miernikiewicz, K D±browska, A Piotrowicz, B Owczarek, J Wojas-Turek, ... PLoS One 8 (8), e71036, 2013 | 102 | 2013 |
